Alpha Cognition Inc. Payments of Stock Issuance Costs
Alpha Cognition Inc. (ACOG) reported Payments of Stock Issuance Costs of $2.55 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-31
- Alpha Cognition Inc. payments of stock issuance costs for the quarter ending 2024-12-31 was $5.30M, a 701.31% increase year-over-year.
- Alpha Cognition Inc. payments of stock issuance costs for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Alpha Cognition Inc. payments of stock issuance costs for the quarter ending 2024-06-30 was $0.00.
- Alpha Cognition Inc. payments of stock issuance costs for the quarter ending 2024-03-31 was $405.75K.
- Alpha Cognition Inc. payments of stock issuance costs for fiscal 2025 was $2.55M, a 55.35% decline from fiscal 2024.
- Alpha Cognition Inc. payments of stock issuance costs for fiscal 2024 was $5.70M, a 440.20% increase from fiscal 2023.
- Alpha Cognition Inc. payments of stock issuance costs for fiscal 2023 was $1.06M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.55M 10-K · filed 2026-03-31 | |||
| 2024-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.30M derived: sum of 2 quarters · filed 2026-03-31 | $5.30M derived: sum of 3 quarters · filed 2026-03-31 | $5.70M 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $405.75K 10-Q · filed 2025-11-13 | $1.07M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $405.75K 10-Q · filed 2025-08-14 | $1.07M derived: sum of 3 quarters · filed 2025-08-14 | $1.25M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $405.75K 10-Q · filed 2025-05-15 | $1.07M derived: sum of 2 quarters · filed 2025-05-15 | $1.25M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $661.25K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $847.30K derived: sum of 2 quarters · filed 2025-03-31 | $1.06M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $186.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $394.74K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $208.69K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |